PegIFN-alfa2a
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PegIFN-alfa2a, covering 2018-01-29 to 2018-01-29. Get the full timeline:
Most recent: Clinical Trial Update: HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis [Phase 2]